| [1] |
Shiraishi T, Getzenberg RH, Kulkarni P. Cancer/testis antigens: novel tools for discerning aggressive and non-aggressive prostate cancer[J]. Asian J Androl,2012,14(3):400-4.
|
| [2] |
Lim SH, Zhang Y, Zhang J. Cancer-testis antigens: the current status on antigen regulation and potential clinical use[J]. Am J Blood Res,2012,2(1):29-35.
|
| [3] |
Mirandola L, J Cannon M, Cobos E, et al. Cancer testis antigens: novel biomarkers and targetable proteins for ovarian cancer[J]. Int Rev Immunol,2011, 30(2-3):127-37.
|
| [4] |
Gnjatic S, Nishikawa H, Jungbluth AA, et al.NY-ESO-1: review of an immunogenic tumor antigen[J]. Adv Cancer Res,2006,95:1-30.
|
| [5] |
Nicholaou T, Ebert L, Davis ID, et al. Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NYESO- 1[ J]. Immunol Cell Biol,2006,84(3):303-17.
|
| [6] |
Karbach J, Neumann A, Atmaca A,et al.Effi cient in vivo priming by vaccination with recombinant NY-ESO-1 protein and CpG in antigen naive prostate cancer patients[J]. Clin Cancer Res,2011,17(4):861-70.
|
| [7] |
Chen YT, Scanlan MJ, Sahin U,et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening[J]. Proc Natl Acad Sci U S A,1997,94(5):1914-8.
|
| [8] |
Goff SL, Robbins PF, El-Gamil M, et al. No correlation between clinical response to CTLA-4 blockade and presence of NY-ESO-1 antibody in patients with metastatic melanoma[J]. J Immunother, 20 09,32(8):884-5.
|
| [9] |
Luo G, Huang S, Xie X, et al. Expression of cancer-testis genes in human hepatocellular carcinomas[J]. Cancer Immun,2002,2:11.
|
| [10] |
Vermeij R, Daemen T, de Bock GH, et al. Potential target antigens for a universal vaccine in epithelial ovarian cancer[J]. Clin Dev Immunol,2010,2010.
|
| [11] |
Shigematsu Y, Hanagiri T, Shiota H,et al. Clinical signifi cance of cancer/testis antigens expression in patients with non-small cell lung cancer[J]. Lung Cancer,2010,68(1):105-10.
|
| [12] |
Xie C, Kim HJ, Haw JG, et al. A novel multiplex assay combining autoantibodies plus PSA has potential implications for classifications of prostate cancer from non-malignant cases[J]. J Trans Med,2011,9:43.
|
| [13] |
Fiset PO,Aprikian A,Brimo F.Length of prostate biopsy cores: does it impact cancer detection?[J]. Can J Urol,2013,20(4):6848-53.
|
| [14] |
Egevad L, Granfors T, Karlberg L, et al. Prognostic value of the Gleason score in prostate cancer[J]. BJU Int,2002,89(6):538-42.
|
| [15] |
Epstein JI, Potter SR. The pathological interpretation and significance of prostate needle biopsy findings: implications and current controversies[J]. J Urol,2001,166(2):402-10.
|
下载:
